Bioventus: Q2 Earnings Insights - Bioventus (NASDAQ:BVS)

Bioventus BVS reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Bioventus missed estimated earnings by 37.5%, reporting an EPS of $0.1 versus an estimate of $0.16.

Revenue was up $30.52 million from the same period last year.

Last quarter the company missed on EPS by $0.01 which was followed by a 4.95% drop in the share price the next day.

Here's a look at Bioventus's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	0.05	0.18	0.14	0.15
EPS Actual	0.04	0.26	0.25	0.16
Revenue Estimate	117.69M	130.29M	102.23M	97.64M
Revenue Actual	117.29M	130.41M	108.89M	109.82M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Bioventus management provided guidance for FY 2022, expecting earnings between $0.47 and $0.57 per share.

To track all earnings releases for Bioventus visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.